Human Prothrombin ELISA Kit
Prothrombin (aka Factor II) is a single-chain vitamin K-dependent 579 amino acid glycoprotein zymogen. Prothrombin is proteolytically activated to thrombin by the prothrombinase enzyme complex in the coagulation cascade common pathway. The serine protease thrombin converts plasma fibrinogen to insoluble fibrin. Prothrombin levels are decreased by anticoagulant therapy, vitamin K deficiency and severe liver disease. Elevated plasma prothrombin is associated with a single nucleotide change at position 20210.
This human prothrombin antigen assay is intended for the quantitative determination of total prothrombin antigen in human plasma. The assay measures human prothrombin antigen in the 0.25 - 100 ng/ml range. If the unknown is thought to have high prothrombin levels, dilutions may be made in blocking buffer. A 1:5,000-1:40,000 dilution for normal human plasma is suggested for best results. Strip well format. Reagents for up to 96 tests.
Human prothrombin will bind to the capture antibody coated on the microtiter plate. Prothrombin, thrombin, and thrombin-antithrombin complex will react with the antibody on the plate. After appropriate washing steps, anti-human prothrombin primary antibody binds to the captured protein. Excess primary antibody is washed away and bound antibody is reacted with the secondary antibody. Following an additional washing step, TMB substrate is used for color development at 450nm. A standard calibration curve is prepared along with the samples to be measured using dilutions of human prothrombin. Color development is proportional to the concentration of total prothrombin in the samples.
Detection Target: Prothrombin
Range: 0.25 - 100 ng/ml
Sensitivity: 0.078 ng/ml
Disclaimer: This material is sold for in-vitro use only for manufacturing and research. This material is not suitable for human or animal use. While we make every effort to ensure the safety of our products, we recommend handling any biological materials with standard precautions as if capable of spreading infectious disease. The statements herein are offered for informational purposes only to be used solely for your consideration, investigation, and verification.